MyoKardia (MYOK) Files for $86.25M Common Stock IPO

MyoKardia, Inc. (Nasdaq: MYOK) filed a registration for an IPO of its Common Stock. The proposed maximum offering price is $86.25 million. The company plans to list on the Nasdaq under the symbol, MYOK.

Underwriters are Credit Suisse, Cowen and Company, BMO Capital Markets, and Wedbush PacGrow.

MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Musk's SpaceX Prices Record Ipo At $135 A Share, Raising $75 Billion, Source Says - Reuters
• Nasdaq Anticipates SpaceX IPO To Open For Trading Shortly - Bloomberg